Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury
Franco R. D’Alessio, … , John F. McDyer, Landon S. King
Franco R. D’Alessio, … , John F. McDyer, Landon S. King
Published September 21, 2009
Citation Information: J Clin Invest. 2009;119(10):2898-2913. https://doi.org/10.1172/JCI36498.
View: Text | PDF
Research Article

CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury

  • Text
  • PDF
Abstract

Acute lung injury (ALI) is characterized by rapid alveolar injury, inflammation, cytokine induction, and neutrophil accumulation. Although early events in the pathogenesis of ALI have been defined, the mechanisms underlying resolution are unknown. As a model of ALI, we administered intratracheal (i.t.) LPS to mice and observed peak lung injury 4 days after the challenge, with resolution by day 10. Numbers of alveolar lymphocytes increased as injury resolved. To examine the role of lymphocytes in this response, lymphocyte-deficient Rag-1–/– and C57BL/6 WT mice were exposed to i.t. LPS. The extent of injury was similar between the groups of mice through day 4, but recovery was markedly impaired in the Rag-1–/– mice. Adoptive transfer studies revealed that infusion of CD4+CD25+Foxp3+ Tregs as late as 24 hours after i.t. LPS normalized resolution in Rag-1–/– mice. Similarly, Treg depletion in WT mice delayed recovery. Treg transfer into i.t. LPS–exposed Rag-1–/– mice also corrected the elevated levels of alveolar proinflammatory cytokines and increased the diminished levels of alveolar TGF-β and neutrophil apoptosis. Mechanistically, Treg-mediated resolution of lung injury was abrogated by TGF-β inhibition. Moreover, BAL of patients with ALI revealed dynamic changes in CD3+CD4+CD25hiCD127loFoxp3+ cells. These results indicate that Tregs modify innate immune responses during resolution of lung injury and suggest potential targets for treating ALI, for which there are no specific therapies currently available.

Authors

Franco R. D’Alessio, Kenji Tsushima, Neil R. Aggarwal, Erin E. West, Matthew H. Willett, Martin F. Britos, Matthew R. Pipeling, Roy G. Brower, Rubin M. Tuder, John F. McDyer, Landon S. King

×

Figure 4

Phenotype and function of alveolar Tregs during resolution of ALI.

Options: View larger image (or click on image) Download as PowerPoint
Phenotype and function of alveolar Tregs during resolution of ALI.
(A) H...
(A) Histograms showing the percentage of Foxp3+ cells in the pool of donor CD4+CD25+ splenocytes (AT spleen) as well as in CD4+CD25+ cells recovered in the BAL from LPS-injured Rag-1–/– mice on days 4 and 10 after LPS. Labeling for isotype control Ab at day 10 is also shown. (B) Purified Tregs from naive WT spleens were cultured in the presence or absence of 100 ng/ml LPS and/or macrophages. Representative flow cytometry shows the relationship between Foxp3 and FR4 expression under different conditions. Numbers within plots denote the percentage of cells in the respective quadrants. (C) Relative expression of Foxp3 and FR4 in CD4+CD25+ cells from the experiments in B. †P < 0.05 versus Tregs without LPS or macrophages. (D) Proliferative responses of CD4+CD25– lymphocytes to 0.5 mg/ml anti-CD3 and irradiated APCs (Stimulated) in the presence or absence of CD4+CD25+ cells isolated from spleen or sorted from BAL of WT mice on day 4 after LPS and cultured at the indicated ratios. Unstimulated CD4+CD25– lymphocytes were not exposed to anti-CD3 and irradiated APCs. †P < 0.05 versus media-stimulated CD25– cells.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts